The Pakistani Competition Commission (CCP) has set guidelines for pharmaceutical and herbal enterprises to advertise, promote, and sell weight reduction goods.
The development comes after the CCP issued a suo moto warning to companies who advertise, promote, and sell weight-loss products while obfuscating the goods’ possible negative effects.
The CCP initiated action against 14 pharmaceutical and herbal enterprises that were advertising, marketing, and selling weight reduction treatments while obfuscating the items’ possible negative effects.
A CCP bench made up of senior members issued an injunction against firms that offer weight-loss products, demonstrating that the whole sector engages in dishonest marketing techniques.
The respondent firms’ activities and potential anti-competitive impacts were discovered to have interprovincial spillover effects, as the respondents operated and sold their products all throughout Pakistan, including the federal capital, in addition to their online operations through websites. Anti-competitive activity would spread beyond the borders of a particular province or region, affecting trade and commerce.
The CCP bench found that commercials provided a false perception regarding weight reduction goods, leading to the public’s belief that these products might produce miraculous results in a short period of time. It was noticed that the businesses had been advertising/marketing and selling these medications without disclosing any potential negative effects that may emerge as a result of continuous use.
“The companies have also failed to disclose to their consumers the potential impact their product can have on people with various medical conditions, such as diabetes, hypertension, allergies, and other medical conditions, which may cause life-threatening effects on consumers suffering from certain medical conditions,” according to the CCP bench.